Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
E Martino, G Casamassima, S Castiglione… - Bioorganic & medicinal …, 2018 - Elsevier
Cancer still represents a “nightmare” worldwide, causing annually millions of victims.
Several antiproliferative molecules are currently used as drugs market and offer a …
Several antiproliferative molecules are currently used as drugs market and offer a …
Imidazoles as potential anticancer agents
Cancer is a black spot on the face of humanity in this era of science and technology.
Presently, several classes of anticancer drugs are available in the market, but issues such …
Presently, several classes of anticancer drugs are available in the market, but issues such …
[图书][B] DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology
VT DeVita, TS Lawrence, SA Rosenberg - 2008 - books.google.com
Acclaimed by the worldwide medical community as" a staple reference text in the medical
oncologist's library"(JAMA), DeVita, Hellman, and Rosenberg's Cancer: Principles and …
oncologist's library"(JAMA), DeVita, Hellman, and Rosenberg's Cancer: Principles and …
[HTML][HTML] Antibody drug conjugates: lessons from 20 years of clinical experience
AW Tolcher - Annals of Oncology, 2016 - Elsevier
The antibody drug conjugate platform and why it has not reached the potential of this
technology. Antibody drug conjugates are complex delivery systems for selective delivery of …
technology. Antibody drug conjugates are complex delivery systems for selective delivery of …
Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?
P Sève, C Dumontet - The lancet oncology, 2008 - thelancet.com
On the basis of preclinical studies that show overexpression of class III β-tubulin is
associated with resistance to tubulin-binding agents, several investigators have addressed …
associated with resistance to tubulin-binding agents, several investigators have addressed …
The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review
LG Wang, XM Liu, W Kreis, DR Budman - Cancer chemotherapy and …, 1999 - Springer
Purpose: Microtubules are important cytoskeletal components involved in many cellular
events. Antimicrotubule agents including polymerizing agents (paclitaxel and docetaxel) and …
events. Antimicrotubule agents including polymerizing agents (paclitaxel and docetaxel) and …
[PDF][PDF] Tubulin and microtubules as targets for anticancer drugs
JA Hadfield, S Ducki, N Hirst… - Progress in Cell Cycle …, 2003 - researchgate.net
The vinca alkaloids have been used in the treatment of cancer for over 40 years. Their
efficacy has ensured that they remain among the drugs of choice for a number of human …
efficacy has ensured that they remain among the drugs of choice for a number of human …
Past and future of the mitotic spindle as an oncology target
KW Wood, WD Cornwell, JR Jackson - Current opinion in pharmacology, 2001 - Elsevier
Tubulin poisons were first discovered decades ago, but the recent clinical and commercial
success of Taxol® has led to a renaissance in the search for novel mitotic spindle poisons to …
success of Taxol® has led to a renaissance in the search for novel mitotic spindle poisons to …
Platinum-based chemotherapy in metastatic breast cancer: current status
MP Decatris, S Sundar, KJ O'byrne - Cancer treatment reviews, 2004 - Elsevier
Cisplatin and carboplatin are active in previously untreated patients with metastatic breast
cancer (MBC) with mean response rates (RRs) of 50 and 32%, respectively. In pretreated …
cancer (MBC) with mean response rates (RRs) of 50 and 32%, respectively. In pretreated …
[HTML][HTML] Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients
N Tay, EL Laakso, D Schweitzer, R Endersby… - Frontiers in molecular …, 2022 - frontiersin.org
Brain cancer and leukemia are the most common cancers diagnosed in the pediatric
population and are often treated with lifesaving chemotherapy. However, chemotherapy …
population and are often treated with lifesaving chemotherapy. However, chemotherapy …